Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12621001236886Phase 3Completed
Phase 3, randomised, open-label trial in acute severe behavioural disturbance (ASBD) comparing Olanzapine with Diazepam (2 arms). Primary endpoint: Successful sedation without additional sedation at 1 hour. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12621001236886.